Application 212615
- Type
- ANDA
- Sponsor
- GRANULES INDIA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIRFENIDONE | PIRFENIDONE | TABLET;ORAL | 267MG | No | No |
| 002 | PIRFENIDONE | PIRFENIDONE | TABLET;ORAL | 801MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PIRFENIDONE | PIRFENIDONE | Novadoz Pharmaceuticals LLC | 741d1b9c-e281-4eca-b327-e25e82313006 | 2024-07-23 | Warnings, Adverse reactions | PIRFENIDONE PIRFENIDONE |
| PIRFENIDONE | PIRFENIDONE | Northstar Rx LLC | 5d0eee8c-dc7d-4444-8684-e9c9335291c8 | 2024-03-08 | Warnings, Adverse reactions | PIRFENIDONE PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | Alembic Pharmaceuticals Inc. | 9214862e-9ef7-4370-856a-f5697978270a | 2023-12-06 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| PIRFENIDONE | PIRFENIDONE | ScieGen Pharmaceuticals, Inc. | 1fbdb556-b164-4e0b-a95e-6004d50e3364 | 2023-11-09 | Warnings, Adverse reactions | PIRFENIDONE PIRFENIDONE |
| PIRFENIDONE | PIRFENIDONE | ScieGen Pharmaceuticals, Inc. | 155b948e-47f5-4741-8e82-2ed65ccfab7d | 2023-11-08 | Warnings, Adverse reactions | PIRFENIDONE PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | Camber Pharmaceuticals, Inc. | a7f3485e-9dcc-45db-9b9c-74c70e22c4bb | 2023-05-11 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | Sandoz Inc | 7f5f7cc9-394e-4da0-87eb-84cfff9707a3 | 2023-04-30 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | Amneal Pharmaceuticals NY LLC | a235768d-d26d-4ded-ae75-53e93310ff6a | 2023-04-10 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | Alembic Pharmaceuticals Limited | 6e4f991a-c9e3-4121-97d0-d07954f17336 | 2023-03-30 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| PIRFENIDONE | PIRFENIDONE | EXELAN PHARMACEUTICALS INC. | 1709582c-9975-4dc1-8181-2501ee670eef | 2023-01-20 | Warnings, Adverse reactions | PIRFENIDONE PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | Cipla USA Inc. | 1927bf5d-1ef3-4a36-8dac-dc0a45b72fec | 2022-08-26 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| Pirfenidone | PIRFENIDONE | EXELAN PHARMACEUTICALS INC. | c171e4af-1619-4712-958f-ef96adfede37 | 2022-08-08 | Warnings, Adverse reactions | Pirfenidone PIRFENIDONE |
| PIRFENIDONE | PIRFENIDONE | Cipla USA Inc. | 16fca4fc-b641-4ee8-a2ee-a35189ce1f3b | 2022-08-03 | Warnings, Adverse reactions | PIRFENIDONE PIRFENIDONE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.